|
|
|
Sunday, March 18, 2012 — 1:30 p.m. — Convention Centre 211-214
|
- Novel Insights of High-throughput Technologies in Hematopoietic Conditions
|
|
Moderators:
|
Daniel A. Arber, Stanford University, Stanford, CA and Kojo Elenitoba-Johnson, University of Michigan, Ann Arbor, MI
|
Click the button above to add this event to your Itinerary Planner...
| 1:30 |
High Throughput Sequencing in Malignant Lymphoma - Randy D. Gascoyne, BC Cancer Agency and BC Cancer Research Centre, Vancouver, BC, Canada |
| 2:00 |
Methylomic Profiling in Acute Myeloid Leukemia - Maria E. Figueroa, University of Michigan, Ann Arbor, MI |
| 2:30 |
MicroRNAs in Myelodysplastic Syndromes - Aly Karsan, British Columbia Cancer Research Centre, Vancouver, BC, Canada |
| 3:00 | Break |
| 3:30 |
Introduction and Overview of Proteomics in Lymphoma - Kojo Elenitoba-Johnson, University of Michigan, Ann Arbor, MI |
| 4:00 |
Practical Use of New Technologies in Hematopathology - Dan Jones, Quest Diagnostics Nichols Institute, Chantilly, VA |
| 4:30 | Question and Answer Session |
| The topic was chosen by the Executive Committee of the Society for Hematopathology at the recommendation of the membership because high-throughput technologies are being used increasingly in the investigation of hematopoietic proliferations and our members need to be familiar with these techniques. The field of hematopathology has traditionally led in the clinical use of advanced technology for the diagnosis, classification and monitoring of disease. This symposium will introduce the newest technologies, including high throughput sequencing, methylation profiling, detection of microRNAs and applications of proteomics in the study of hematopoietic proliferations. The audience will learn advances already made from the use of these technologies as well as how these methods may impact diagnostic pathology in the future. |
|
|
|
